Journal List > Tuberc Respir Dis > v.70(6) > 1001625

TOOLS
Park: Respiratory Vaccination
Review
Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases 2011; 70(6): 457-461.

Published online: 30 June 2011

DOI: https://doi.org/10.4046/trd.2011.70.6.457

Respiratory Vaccination

Sang-Won Park, M.D., Ph.D.

Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

Address for correspondence: Sang-Won Park, M.D., Ph.D. Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, 31-1, Boramae-gil, Dongjak-gu, Seoul 156-707, Korea. Phone: 82-2-870-2224, Fax: 82-2-870-3863, hswon1@snu.ac.kr

Received 23 December 2010       Accepted 23 December 2010

Copyright © 2011. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Abstract

Vaccination in adults is recommended according to the age group and underlying diseases or risks of exposure. Patients with chronic diseases including chronic obstructive pulmonary diseases are susceptible to infectious diseases and related serious complications. They need risk-related vaccination along with age-related vaccination. Both influenza and pneumococcal vaccination are recommended in patients with chronic obstructive pulmonary diseases. They are additive if administered simultaneously. Pertussis vaccination is also needed in adolescents and adults. Although there is strong need for these vaccinations, the actual vaccination rate is low. Measures to effectively enhance the vaccination rate are needed.

Keywords: Influenza, Human, Streptococcus pneumoniae, pertussis, Vaccination, Respiratory Tract Infections

Figures and Tables

Figure 1
Vaccines that might be indicated for adults, based on medical and other indications. This figure is reprinted from the articley by Centers for Control and Prevention (CDC) [2011]2.
trd-70-457-g001

References

1. Korean Society of Infectious Diseases. Vaccination for adult. 2007. Seoul, Korea: Goonja publication.
2. Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule--United States, 2011. MMWR Morb Mortal Wkly Rep. 2011. 60:1–4.
3. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest. 1995. 108:2 Suppl. 43S–52S.
4. Sapey E, Stockley RA. COPD exacerbations. 2: aetiology. Thorax. 2006. 61:250–258.
5. Neuzil KM, Reed GW, Mitchel EF Jr, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA. 1999. 281:901–907.
6. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. 1999. 281:908–913.
7. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998. 158:1769–1776.
8. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999. 130:397–403.
9. Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, et al. Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence. Vaccine. 2010. 28:3929–3935.
10. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010. 59:1–62.
11. Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med. 1999. 159:2437–2442.
12. Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine. 1999. 17:Suppl 1. S91–S93.
13. Schenkein JG, Nahm MH, Dransfield MT. Pneumococcal vaccination for patients with COPD: current practice and future directions. Chest. 2008. 133:767–774.
14. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003. 348:1747–1755.
15. Schenkein JG, Nahm MH, Dransfield MT. Pneumococcal vaccination for patients with COPD: current practice and future directions. Chest. 2008. 133:767–774.
16. Furumoto A, Ohkusa Y, Chen M, Kawakami K, Masaki H, Sueyasu Y, et al. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine. 2008. 26:4284–4289.
17. Park WB, Park SW, Kim HB, Kim EC, Oh M, Choe KW. Pertussis in adults with persistent cough in South Korea. Eur J Clin Microbiol Infect Dis. 2005. 24:156–158.
TOOLS
Similar articles